Internal Medicine, Hematology & Oncology · Belpre, OH
NPI
1023113727
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
807 Farson St Ste 210
Belpre, OH, 45714
Phone (740) 376-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
2,154 services
Medicare patients, 2024
910
Average age 74
Drug cost, 2024
$8.7M
5,938 prescriptions
Company payments, 2025
$965
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelli A Cawley was code 99214 (office e&m - established), 934 times for 539 patients. In total Kelli A Cawley billed 2,154 services in 17 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 934 | 539 | $68.77 | $64K |
| 99213 Office E&M - Established | Facility | 369 | 320 | $45.11 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 323 | 123 | $58.36 | $19K |
| 99222 Hospital E&M - Initial | Facility | 199 | 159 | $95.86 | $19K |
| 99231 Hospital E&M - Subsequent | Facility | 70 | 46 | $36.92 | $2,584 |
| 99204 Office E&M - New | Facility | 42 | 42 | $98.83 | $4,151 |
| 99215 Office E&M - Established | Facility | 38 | 34 | $104.26 | $3,962 |
| 99223 Hospital E&M - Initial | Facility | 38 | 34 | $125.57 | $4,772 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 22 | $88.45 | $2,919 |
| 99212 Office E&M - Established | Facility | 30 | 30 | $17.55 | $526 |
| 99239 Hospital Discharge Management | Facility | 21 | 15 | $84.97 | $1,784 |
| 99203 Office E&M - New | Facility | 21 | 21 | $50.09 | $1,052 |
| 99238 Hospital Discharge Management | Facility | 16 | 13 | $57.30 | $917 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $61.75 | $803 |
By year: 2022 $81K for 1,209 services; 2023 $94K for 1,287 services; 2024 $143K for 2,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelli A Cawley prescribed most often to Medicare patients was Anastrozole, with 466 prescriptions and refills. In total Kelli A Cawley wrote 5,938 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 466 | 1,085 | 134 | $7,427 |
| Eliquis Apixaban | 251 | 326 | 50 | $184K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 189 | 189 | 66 | $3,567 |
| Prednisone Generic | 183 | 208 | 79 | $830 |
| Olanzapine Generic | 178 | 201 | 69 | $2,532 |
| Acyclovir Generic | 177 | 279 | 41 | $1,982 |
| Potassium Chloride Generic | 173 | 242 | 53 | $3,259 |
| Xarelto Rivaroxaban | 146 | 196 | 30 | $107K |
| Allopurinol Generic | 131 | 203 | 43 | $563 |
| Ondansetron Hcl Generic | 126 | 128 | 60 | $2,406 |
| Oxycodone Hcl Generic | 122 | 122 | 34 | $3,658 |
| Dexamethasone Generic | 115 | 133 | 64 | $2,202 |
| Letrozole Generic | 111 | 271 | 33 | $2,611 |
| Tamoxifen Citrate Generic | 111 | 260 | 31 | $2,796 |
| Gabapentin Generic | 109 | 147 | 36 | $1,374 |
Brand drugs: 1,069 claims; generic drugs: 4,844 claims; opioid claims: 519.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelli A Cawley $965 ($965 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 17 | $267 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $192 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $139 |
| Celgene Corporation BMY | 3 | $60.72 |
| Abbvie Inc. ABBV | 2 | $47.39 |
| Aveo Pharmaceuticals, Inc. | 2 | $43.92 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $43.29 |
| Kite Pharma, Inc. GILD | 2 | $32.65 |
| SpringWorks Therapeutics, Inc. | 1 | $28.42 |
| EMD Serono, Inc. MRK.DE | 1 | $24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.